Cardinal Health Debt to Equity Ratio 2010-2025 | CAH

Current and historical debt to equity ratio values for Cardinal Health (CAH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cardinal Health debt/equity for the three months ending March 31, 2025 was 0.00.
Cardinal Health Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $51.77B $-1.90B -27.28
2024-12-31 $49.92B $-2.92B -17.09
2024-09-30 $46.34B $-3.28B -14.14
2024-06-30 $48.33B $-3.21B -15.05
2024-03-31 $49.14B $-3.26B -15.07
2023-12-31 $50.02B $-3.45B -14.51
2023-09-30 $47.20B $-3.49B -13.52
2023-06-30 $46.31B $-2.96B -15.66
2023-03-31 $45.60B $-2.22B -20.56
2022-12-31 $46.69B $-2.21B -21.11
2022-09-30 $45.17B $-1.78B -25.38
2022-06-30 $44.58B $-0.71B -63.15
2022-03-31 $42.80B $-0.69B -61.77
2021-12-31 $42.68B $1.00B 42.59
2021-09-30 $41.60B $1.40B 29.80
2021-06-30 $42.66B $1.79B 23.78
2021-03-31 $42.08B $1.79B 23.46
2020-12-31 $42.74B $1.98B 21.64
2020-09-30 $40.30B $1.43B 28.28
2020-06-30 $38.97B $1.79B 21.75
2020-03-31 $39.94B $1.21B 33.12
2019-12-31 $40.04B $1.00B 39.96
2019-09-30 $38.28B $0.90B 42.39
2019-06-30 $34.63B $6.33B 5.47
2019-03-31 $34.58B $6.23B 5.55
2018-12-31 $34.42B $6.04B 5.70
2018-09-30 $34.10B $5.91B 5.77
2018-06-30 $33.89B $6.06B 5.59
2018-03-31 $33.49B $7.54B 4.44
2017-12-31 $35.29B $7.62B 4.63
2017-09-30 $35.25B $6.70B 5.26
2017-06-30 $33.28B $6.83B 4.88
2017-03-31 $27.51B $6.67B 4.13
2016-12-31 $28.68B $6.34B 4.52
2016-09-30 $27.88B $6.53B 4.27
2016-06-30 $27.55B $6.57B 4.19
2016-03-31 $27.33B $6.73B 4.06
2015-12-31 $26.78B $6.73B 3.98
2015-09-30 $24.70B $6.53B 3.78
2015-06-30 $23.89B $6.26B 3.82
2015-03-31 $21.52B $6.37B 3.38
2014-12-31 $21.15B $6.10B 3.47
2014-09-30 $19.46B $6.26B 3.11
2014-06-30 $19.63B $6.40B 3.07
2014-03-31 $18.17B $6.53B 2.78
2013-12-31 $18.42B $6.59B 2.80
2013-09-30 $17.52B $6.30B 2.78
2013-06-30 $19.84B $5.98B 3.32
2013-03-31 $19.89B $6.83B 2.91
2012-12-31 $18.10B $6.54B 2.77
2012-09-30 $18.54B $6.28B 2.95
2012-06-30 $18.02B $6.24B 2.89
2012-03-31 $18.40B $6.24B 2.95
2011-12-31 $18.34B $5.93B 3.09
2011-09-30 $17.47B $5.71B 3.06
2011-06-30 $17.00B $5.85B 2.91
2011-03-31 $17.54B $5.66B 3.10
2010-12-31 $17.43B $5.42B 3.22
2010-09-30 $15.73B $5.24B 3.00
2010-06-30 $14.71B $5.28B 2.79
2010-03-31 $15.91B $5.36B 2.97
2009-12-31 $15.60B $5.23B 2.98
2009-09-30 $15.49B $4.94B 3.14
2009-06-30 $16.39B $8.73B 1.88
2009-03-31 $17.10B $8.44B 2.03
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $37.506B $226.827B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.057B 21.50
Becton Dickinson (BDX) United States $53.114B 13.15
Straumann Holding AG (SAUHY) Switzerland $21.989B 0.00
West Pharmaceutical Services (WST) United States $18.932B 37.86
Cooper (COO) United States $14.917B 19.22
Align Technology (ALGN) United States $14.900B 29.58
Henry Schein (HSIC) United States $8.698B 14.92
Merit Medical Systems (MMSI) United States $5.005B 24.20
DENTSPLY SIRONA (XRAY) United States $3.195B 9.54
CONMED (CNMD) United States $1.576B 11.79
STAAR Surgical (STAA) United States $0.951B 0.00
Lifevantage (LFVN) United States $0.173B 17.81
Pro-Dex (PDEX) United States $0.161B 17.65